Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PET Metabolic Activity, Clinical Stages, and Survival Outcome
Journal
Diagnostics (Basel, Switzerland)
Journal Volume
11
Journal Issue
9
Date Issued
2021-08-25
Author(s)
Abstract
To compare the metabolites of in vivo 1H- MRS in pancreatic cancer with normal pancreas, and correlate these metabolites with Positron Emission Tomography (PET) metabolic activity, clinical stages, and survival outcomes.
Subjects
MR spectroscopy; pancreatic cancer; positron emission tomography; survival
SDGs
Other Subjects
creatine; fluorodeoxyglucose f 18; glutamic acid; glutamine; lipid; n acetylaspartic acid; adult; aged; Article; cancer staging; cancer survival; clinical evaluation; comparative study; conservative treatment; controlled study; correlation analysis; distal pancreatectomy; female; glycolysis; human; in vivo study; lipid level; major clinical study; male; maximum standardized uptake value; metabolic regulation; metabolic tumor volume; middle aged; nonparametric test; nuclear magnetic resonance imaging; outcome assessment; overall survival; pancreas; pancreas adenocarcinoma; pancreas cancer; pancreatic ductal carcinoma; positron emission tomography; progression free survival; prospective study; proton nuclear magnetic resonance; radiological parameters; tumor volume
Type
journal article